Home News Canada

01

Mar2023

INESSS Fee Schedule Update; Upcoming CADTH Consultation and Application Process Updates

INESSS has published its updated fee schedule for its scientific evaluation of drugs, stable blood products and technologies in the February 18, 2023 Gazette du Québec. Fees for all submission types have increased 6.44% as of January 1, 2023, bringing fees to: $63,791 for a new ... Read More

20

Dec2022

Updates to the Quebec Guidelines for Drug Submission and Evaluation

The Institut national d’excellence en Santé et en services sociaux (INESSS) has recently updated the Guidance Document for Submitting a Request to INESSS and affiliate documents. This document consolidates updates previously communicated through manufacturer notices and replaces the 2018 version of the guidelines.  ... Read More

22

Nov2022

PDCI Launches Sharing Page for PMRPB Consultation on Draft Guidelines- Fall 2022

On October 6, 2022, the Patented Medicine Prices Review Board (PMPRB) published its Draft price regulatory Guidelines and has invited stakeholders to comment on its approach by December 5, 2022. PDCI strives to support timely transparency around public policy consultations and invites organizations and individuals who provided comments to ... Read More

22

Nov2022

CADTH Pharmaceutical Reviews Update Includes Launch of RWE Guidance Consultation

On November 10, 2022, among other procedural updates included in the CADTH Pharmaceutical Reviews Update Issue 32, CADTH published its Real-World Evidence (RWE) Steering Committee’s anticipated Proposed RWE Reporting Guidance and initiated a public consultation on the guidance open now through January 6, 2023.What to know: The ... Read More

31

Jan2022

Updates to the Ontario Guidelines for Drug Submission and Evaluation

The Ontario Ministry of Health has recently updated the Ontario Guidelines for Drug Submission and Evaluation (Guidelines). In an effort to reduce complexity and simplify their policy document, specific guidelines aiming to address individual product types are now available on the Ontario Ministry of Health website.... Read More

17

Dec2021

Consultation Notice: Proposed Framework for a Potential Pan-Canadian Formulary

Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022.  A discussion paper summarizing the Advisory Panel’s interim recommendations and proposed process will be posted on the CADTH website and CADTH will host an information session on January 18, 2022 at 1 p.m. (ET).  ... Read More

20

May2021

PDCI at ISPOR: Poster Presentation on Oncology Companion Diagnostics

ISPOR 2021 runs between May 17-20 with the theme of HEOR: Evolving for Tomorrow's Challenges. During the conference, PDCI Market Access will be presenting a poster titled: Identification of Gaps and Opportunities for Provincial Reimbursement of Oncology Companion Diagnostics in Canada on May 18th 2021 from 11:30:00 AM ... Read More

03

Dec2020

INESSS Announces the Establishment of a Waiting List for Scientific Evaluations

INESSS has announced the implementation of a waiting list for requests for scientific evaluation received by INESSS as of November 16, 2020. PDCI has outlined below the key highlights from the most recent newsletter. The Institut national d’excellence en santé et en services sociaux (INESSS) has reported a ... Read More

30

Sep2020

PDCI PLA Study Report – PDCI Market Access Inc., Connex Health Consulting, H3 Consulting

PDCI-PLA-Study-Report-PDCI-Market-Access-Inc.-Connex-Health-Consulting-H3-ConsultingDownload

09

Sep2020

Cell & Gene Therapy Insights

Palmer-Cell-and-Gene-Theraoy-InsightsDownload